Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct 1;9(4):185-92.

Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy

Behzad Poopak  1 , Saghar Rabieipoor  2 , Nazila Safari  3 , Emadedin Naraghi  4 , Fatemeh Sheikhsofla  5 , Gelareh Khosravipoor  6
Affiliations

Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy

Behzad Poopak et al. Int J Hematol Oncol Stem Cell Res. .

Abstract

Background: Although catalytic properties of different genetic polymorphisms of VKORC1 and CYP2C9 products have been identified, there is limited study available regarding warfarin dose requirement in Iranian patient population. This study investigates the impact of these polymorphisms on 115 patients, referred to Payvand Clinical and Specialty Laboratory for determining the appropriate dose of warfarin. RESULTS of the study may be applicable to individuals who are under warfarin therapy to avoid warfarin resistance or intolerance.

Subjects and methods: PT-INR test was utilized as a screening method. Genotyping were performed for VKORC1 and CYP2C9 using PCR method. Statistical analyses including unpaired t-test or ANOVA and regression were done using SPSS.

Results: VKORC1 GA was the most common genotype of VKORC1 allele among the study samples, with a rate of 57.4%. In CYP2C9 variant, 20% and 14.8% of subjects carried CYP2C9*1/*2 and CYP2C9*1/*3 genotyping, respectively. By contrast, the WT *1/*1 genotype was more abundant and dominant. The high frequency of VKORC1 (_1639) GA genotype (57.4%), was significant versus for the rest of the cohort (42.6%). In addition, a significant relationship was found between CYP2C9*1 and drug dose (P>0.021).

Conclusion: In this study, samples were characterized by higher frequencies of CYP2C9*1 and VKORC1 G/A, determined as higher warfarin taking doses. The results showed a significant relationship of the VCORC1 and CYP2C9 polymorphisms with warfarin sensitivity and severe side effects. Estimating right doses of warfarin to prescribe can help to reduce the risk of over- or under-anticoagulation and subsequently, the risk of thromboembolism or bleeding.

Keywords: CYP2C9 and VKORC1 polymorphisms; Polymerase Change Reaction; Warfarin dose requirements.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationship between daily warfarin dosage and age
Figure 2
Figure 2
Relationship between genetic polymorphisms and recommended daily warfarin dose (in milligrams)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Yin T, Miyata T. Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1-Rationale and perspectives. Thromb Res. 2007;120(1):1–10. - PubMed
    1. Zambon CF, Pengo V, Padrini R, et al. VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study. Pharmacogenomics . 2011;12(1):15–25. - PubMed
    1. Samiee SM, Mohammadi Yeganeh S, Paryan M, et al. Polymorphism Detection of VKORC1 and CYP2C9 genes for warfarin dose adjustment by Real-Time PCR. Thrita. 2014;3(1):e14033.
    1. Wadelius M, Chen LY, Downes K, et al. Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Pharmacogenomics. 2005;5(4):262–70. - PubMed
    1. Schwarz UI, Ritchie MD, Bradford Y, et al. Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med. 2008;358(10):999–1008. - PMC - PubMed

LinkOut - more resources